For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Search Posts
Blog
FDA Tobacco Regulation Assailed
In the New York Times, Patrick Basham explains why the bill to give the Food and Drug Administration the duty to regulate tobacco is…
Blog
Goofy’s Coffin Nails
When it comes to the politics of tobacco regulation, one of the most important dates is January 11, 1964, when then-Surgeon General Luther L. Terry…
Blog
FDA Tobacco Regulation Clears Senate Committee
A Senate committee has just voted 13-to-8 in favor of the bill to give the FDA jurisdiction over tobacco products and the tobacco industry.
Newsletter
CEI Daily Update
Issues in the News 1. BUSINESS Supermarket chain Whole Foods pursues a buyout bid for rival Wild Oats Markets. CEI…
Newsletter
CEI Daily Update
Issues in the News 1. LEGAL The Federalist Society hosts a forum on state attorney general activism. …
Blog
FDA Tobacco Regulation Bill Tramples Free Speech, Advertisers Say
Advertisers are objecting to the bill that would subject the tobacco industry to FDA regulation, saying that its restrictions on tobacco advertising would violate…